363 results on '"Ogawa, Chitose"'
Search Results
2. Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children’s Cancer Group
3. Successful treatment of pediatric patients with high-grade gliomas featuring leptomeningeal metastases by targeting BRAF V600E mutations with dabrafenib plus trametinib: two illustrative cases
4. TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia
5. Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy
6. Loss of or decrease in CD30 expression in four patients with anaplastic large cell lymphoma after brentuximab vedotin-containing therapy
7. Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia
8. Japan’s contribution to an ongoing global pediatric cancer clinical trial: The experience of the National Cancer Center Hospital (NCCH) in Tokyo
9. Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia
10. Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases
11. A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)
12. KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma
13. Pediatric atypical teratoid/rhabdoid tumor in the cauda equina with rapid tumor progression: A case report and review of the literature
14. Feasibility and usefulness of recommended screenings at long-term follow-up clinics for hematopoietic cell transplant survivors
15. Correction to: A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)
16. Feasibility of multimodal therapy for rhabdomyosarcoma in a patient with Fukuyama congenital muscular dystrophy
17. Boron neutron capture therapy prolongs survival in a patient with a recurrent malignant peripheral nerve sheath tumor—A case report
18. Identification of barriers to implementation of precision oncology in patients with rare cancers
19. Cross‐individual cancer transmission to children during the gestational and perinatal periods
20. Outcomes in children with first‐relapsed acute lymphoblastic leukemia in Japan: Results from JCCG Study JPLSG‐ALL‐R08.
21. Treatment Outcomes of Unilateral Retinoblastoma in Japan - A Single-Center Retrospective Study of 153 Eyes
22. USEFULNESS OF MEASUREMENT OF CD34-POSITIVE CELL COUNT AT MID-APHERESIS PRODUCT SAMPLING IN PERIPHERAL BLOOD STEM CELL COLLECTION
23. FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children’s Cancer Group
24. Use of Pegfilgrastim in Japanese Pediatric Patients With Solid Tumors: A Retrospective Analysis
25. A phase 1b study of blinatumomab in Japanese children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
26. Bortezomib-containing therapy in Japanese children with relapsed acute lymphoblastic leukemia
27. Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 Cases
28. Incidence of skeletal‐related events in patients with Ewing sarcoma: An observational retrospective study in Japan.
29. Different phenotype relapse of myeloid/lymphoid neoplasms with FGFR1 rearrangement with long remission
30. A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib
31. Japanese physicians’ attitudes toward end-of-life discussion with pediatric patients with cancer
32. Surgical management of intertumor abscesses caused by fistulous communications with the intestine: rare complication in pediatric malignant tumor: 2 case reports
33. Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5
34. Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol
35. Correction to: FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children’s Cancer Group
36. Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion
37. Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children’s Cancer Study Group (TCCSG) Study L04-16
38. Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcoma
39. Safety and efficacy of multiple tyrosine kinase inhibitors in pediatric/adolescent and young adult patients with relapsed or refractory osteosarcomas: A single‐institution retrospective analysis
40. FGFR1 tyrosine kinase domain duplication in infantile soft tissue spindle cell tumor
41. Abstract 3995: Trastuzumab deruxtecan, antibody-drug conjugate targeting HER2, effectively inhibits growth of patient-derived xenograft model with CIC-rearranged sarcoma
42. Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography
43. Hematopoietic Stem Cell Transplantation Based on Minimal Residual Disease with a Unified Conditioning Regimen Comprising Total Body Irradiation, Etoposide and Cyclophosphamide: Results from the JPLSG ALL-R08-II Trial, the First Nationwide Prospective Study for Children with Intermediate-Risk Relapsed Acute Lymphoblastic Leukemia in Japan
44. Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
45. Surgical site infection caused by Rhizopus caespitosus after metastasectomy for osteosarcoma: First report of infection in humans
46. Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice
47. The first Japanese biobank of patient‐derived pediatric acute lymphoblastic leukemia xenograft models
48. Plasma asparaginase activity, asparagine concentration, and toxicity after administration of Erwinia asparaginase in children and young adults with acute lymphoblastic leukemia: Phase I/II clinical trial in Japan
49. Pseudo‐Chédiak–Higashi granules and Auer rods in mixed phenotype acute leukaemia, T/myeloid, not otherwise specified
50. Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.